An Evaluation of the EMIT®st Assay for the Detection of Tricyclic Antidepressant Drugs in Plasma or Serum
- 1 January 1984
- journal article
- research article
- Published by Taylor & Francis in Journal of Toxicology: Clinical Toxicology
- Vol. 22 (1) , 63-76
- https://doi.org/10.3109/00099308409035082
Abstract
The EMIT [enzyme multiplied immunoassay technique] assay for tricyclic antidepressant drugs (TAD) was evaluated for use as a screening technique in the detection of these drugs in serum or plasma. The qualitative assay was rapid, easy to perform, required no sample or reagent preparations and reliably detected the TAD in patient samples at concentrations .gtoreq. 200 ng/ml. The technique also detected 17 of 19 patient samples with TAD concentrations ranging from 150-199 ng/ml and 10 of 43 samples with concentrations < 150 ng/ml. The EMIT assay was a reliable technique for detecting high concentrations of TAD and was well-suited for use in emergency drug screening situations.This publication has 9 references indexed in Scilit:
- Imipramine metabolites in blood of patients during therapy and after overdoseClinical Pharmacology & Therapeutics, 1983
- Steady-state plasma concentrations of cis- and trans-10-OH amitriptyline metabolitesClinical Pharmacology & Therapeutics, 1982
- Quantitative liquid-chromatographic technique for the simultaneous assay of tricyclic antidepressant drugs in plasma or serum.Clinical Chemistry, 1982
- Active metabolites of imipramine and desipramine in manClinical Pharmacology & Therapeutics, 1982
- A method for the determination of amitriptyline and its metabolites nortriptyline, 10‐hydroxyamitriptyline, and 10‐hydroxynortriptyline in human plasma using stable isotope dilution and gas chromatography‐chemical ionization mass spectrometry (GC‐CIMS)Clinical Pharmacology & Therapeutics, 1979
- Homogeneous Enzyme Immunoassay TodayScandinavian Journal of Immunology, 1978